NewAmsterdam Pharma Co. NV (NAMS)
33.57
-0.57
(-1.67%)
USD |
NASDAQ |
May 19, 15:04
NewAmsterdam Pharma Shareholders Equity (Quarterly) : 665.22M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 149.34M |
| ProQR Therapeutics NV | 43.32M |
| argenx SE | -- |
| Pharming Group NV | 268.96M |
| Arcutis Biotherapeutics, Inc. | 189.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.64M |
| Total Liabilities (Quarterly) | 67.42M |
| Current Ratio | 9.760 |
| Net Debt Paydown Yield | 0.00% |